Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Leaky Scanning02:28

Leaky Scanning

5.8K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.8K
Improving Translational Accuracy02:07

Improving Translational Accuracy

15.4K
Base complementarity between the three base pairs of mRNA codon and the tRNA anticodon is not a failsafe mechanism. Inaccuracies can range from a single mismatch to no correct base pairing at all. The free energy difference between the correct and nearly correct base pairs can be as small as 3 kcal/ mol. With complementarity being the only proofreading step, the estimated error frequency would be one wrong amino acid in every 100 amino acids incorporated. However, error frequencies observed in...
15.4K
Initiation of Translation02:33

Initiation of Translation

40.0K
Initiating translation is complex because it involves multiple molecules. Initiator tRNA, ribosomal subunits, and eukaryotic initiation factors (eIFs) are all required to assemble on the initiation codon of mRNA. This process consists of several steps that are mediated by different eIFs.
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
40.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Autoantigen mRNA-LNP Vaccination Drives Therapeutic Efficacy in Preclinical Models for Autoimmunity.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

PET rapid image reconstruction challenge (PETRIC).

Frontiers in nuclear medicine·2026
Same author

Efficient motion-corrected image reconstruction for 3D cardiac MRI through stochastic optimisation.

Physics in medicine and biology·2025
Same author

Sequence simplification of antigen coding IVT mRNA allows accelerated synthetic DNA template generation and epitope immunogenicity validation.

Molecular therapy. Nucleic acids·2025
Same author

An mRNA-based workflow validating neo-epitope presentation through HLA-I/peptide affinity purification.

Frontiers in immunology·2025
Same author

Integration of advanced 3D SPECT modelling for pinhole collimators into the open-source STIR framework.

Frontiers in nuclear medicine·2024

Related Experiment Video

Updated: Mar 20, 2026

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

1.5K

Engineering WT1-Encoding mRNA to Increase Translational Efficiency in Dendritic Cells.

Daphné Benteyn1, Carlo Heirman2, Kris Thielemans2

  • 1Laboratory of Molecular and Cellular Therapy, Department of Immunology-Physiology and the Dendritic Cell Bank, Vrije Universiteit Brussel, Laarbeeklaan 103/E235, 1090, Brussels, Belgium. Daphne.benteyn@vub.ac.be.

Methods in Molecular Biology (Clifton, N.J.)
|May 30, 2016
PubMed
Summary

Optimizing messenger RNA (mRNA) modifications enhances antigen expression in dendritic cells (DCs) for cancer immunotherapy. This study details molecular strategies to improve mRNA delivery and expression in DCs for improved immune responses.

Keywords:
Antigen expressionCancerDendritic cellsImmunotherapyVaccinationWilms’ Tumor 1mRNA

More Related Videos

Optimized Protocol for Efficient Transfection of Dendritic Cells without Cell Maturation
08:08

Optimized Protocol for Efficient Transfection of Dendritic Cells without Cell Maturation

Published on: July 8, 2011

21.1K
Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells
10:02

Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells

Published on: June 10, 2022

2.8K

Related Experiment Videos

Last Updated: Mar 20, 2026

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

1.5K
Optimized Protocol for Efficient Transfection of Dendritic Cells without Cell Maturation
08:08

Optimized Protocol for Efficient Transfection of Dendritic Cells without Cell Maturation

Published on: July 8, 2011

21.1K
Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells
10:02

Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells

Published on: June 10, 2022

2.8K

Area of Science:

  • Immunology
  • Molecular Biology
  • Cancer Research

Background:

  • Dendritic cells (DCs) are crucial immune orchestrators used in cancer immunotherapy.
  • Messenger RNA (mRNA) electroporation is a promising technique for modifying DCs.
  • Optimizing mRNA constructs can enhance antigen expression and duration.

Purpose of the Study:

  • To explore molecular modifications of WT1-encoding mRNA.
  • To increase antigen expression and duration from mRNA constructs.
  • To improve the introduction of modified mRNA into dendritic cells.

Main Methods:

  • Designing and synthesizing modified WT1-encoding mRNA constructs.
  • Evaluating antigen expression levels and duration in vitro.
  • Assessing mRNA electroporation efficiency into dendritic cells.

Main Results:

  • Specific molecular modifications significantly increased WT1 antigen expression.
  • Enhanced antigen presentation was observed following mRNA introduction into DCs.
  • Optimized constructs demonstrated improved stability and translation.

Conclusions:

  • Molecular engineering of mRNA templates is effective for boosting antigen expression in DCs.
  • Improved mRNA constructs hold potential for enhancing DC-based cancer vaccines.
  • Further development of mRNA-based immunotherapies is warranted.